Social Media Community Guidelines


AstraZeneca UK Social Media Channels

The @AstrazenecaUK Twitter channel and LinkedIn UK Life Page have been created to highlight the work that AstraZeneca does in the UK. Through the content on this channel, we aim to connect with people across the UK and provide timely updates on our key priorities, our people and our company within the UK.

Because of the regulations governing the healthcare industry, we cannot engage in sensitive topics or talk about any pharmaceutical products or other health treatments on our page. Please adhere to these three simple rules: keep comments on topic, stay positive and be constructive.

We reserve the right to remove any post or comment that violates Twitter and LinkedIn guidelines or the regulations that govern communication within the Pharmaceutical industry. With this in mind, we have outlined the below topics as unwelcome and respectfully request that you avoid posting any comments that include:

  • medical and treatment advice
  • product claims and information
  • patient safety issues (users are welcome to contact us directly through personal messages)
  • contraindicated medications, including but not limited to unapproved medicines or misinformation about medicines
  • off-label and off-licence uses of medications (for example: the use of a medicine for a condition for which it has not been approved, an unapproved dosage)
  • profanity, foul language or personal attacks
  • discriminatory or derogatory comments
  • non-native language
  • infringement on copyrights or trademarks
  • ongoing legal or regulatory matters
  • promotion of illegal activity
  • information that may compromise the safety, security or proceedings of public systems or any criminal or civil investigation
  • spam or promotion of other service/product, or links to other sites

We will not engage with any users that use automation or bots for engagement, spam through excessive replies or comments, or mislead our community with false or deceptive content. We reserve the right to block users who violate our Terms of Use.

If your post references a side effect, we may contact you for more information. AstraZeneca take reports of side effects very seriously and as a pharmaceutical company, we are continuously monitoring the safety of our medicines. In order to do this, we encourage reporting of any side effects experienced while taking an AstraZeneca product to our Medical Information team at 0800 783 0033 or by visiting https://aereporting.astrazeneca.com/. If you get any side effects, talk to a doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine.

Engagements performed by AstraZeneca social media channels in relation to other individuals or organizations on social media (follow, share, like, reply) does not equal an endorsement of all activity and views expressed through those accounts.

AstraZeneca does not endorse information and opinions shared by social media users and they do not represent the views of AstraZeneca. As such AstraZeneca reserves the right to remove any posts which are not in line with these community guidelines.

Thank you for joining our community!

 

Please also see our Privacy Notice and Legal Notice for more information.

GB-24718 | October 2020